0001055726-22-000011.txt : 20220301 0001055726-22-000011.hdr.sgml : 20220301 20220301184843 ACCESSION NUMBER: 0001055726-22-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humeau Laurent CENTRAL INDEX KEY: 0001770390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 22700475 MAIL ADDRESS: STREET 1: C/O INOVIO PHARMACEUTICALS, INC. STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_164617848636087.xml FORM 4 X0306 4 2022-02-26 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001770390 Humeau Laurent C/O INOVIO PHARMACEUTICALS, INC. 6769 MESA RIDGE RD. SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2022-02-26 4 M 0 22545 A 91132 D Common Stock 2022-02-26 4 F 0 8545 3.22 D 82587 D Restricted Stock Unit 2022-02-26 4 M 0 22545 0 D Common Stock 22545.0 45088 D Common Stock Option 3.22 2022-02-26 4 A 0 186000 0 A 2022-02-26 2032-02-26 Common Stock 186000.0 186000 D Restricted Stock Unit 2022-02-26 4 A 0 138800 0 A Common Stock 138800.0 138800 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. The vesting schedule for the 186,000 options is as follows: 46,500 shares vested on February 26, 2022; 46,500 shares will vest on February 26, 2023; 46,500 shares will vest on February 26, 2024; 46,500 shares will vest on February 26, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. /s/ Laurent Humeau 2022-03-01